6533b7d3fe1ef96bd125fe6e
RESEARCH PRODUCT
Treatment of Congestive Heart Failure in the Elderly
P AmatoLigia J. DominguezMario BarbagalloGaspare ParrinelloGiuseppe LicataAnna LicataSalvatore PaternaAntonio Pintosubject
medicine.medical_specialtyeducation.field_of_studyPoor prognosisbusiness.industryAdvanced stagePopulationmedicine.diseaseNatural historyInternal medicineHeart failureCardiologyMedicineIsosorbide dinitratebusinesseducationClinical syndromeCause of deathmedicine.drugdescription
Congestive heart failure (CHF) is a complex clinical syndrome which constitutes the epilogue of the natural history of virtually all heart diseases and in its advanced stages, has a poor prognosis. In the elderly, heart failure exhibits particular characteristics linked to the age-related alterations of cardiovascular system, to the association with other pathologies, to the atypical clinical presentation and to the increased iatrogenic risk. Heart failure now afflicts over 1% of the general population with nearly 1 in 10 elderly subjects affected, and the frequency of CHF is progressively increasing in most industrialized societies1,2. Further, CHF remains a significant cause of death and hospitalization especially among elderly populations. As such, 37,927 deaths and 722,000 hospital discharges were attributed to heart failure in 1990 (Fig. 1).3 Therefore, continued efforts are needed for the primary and secondary prevention of this syndrome.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 1998-01-01 |